Headquartered in the Wynwood neighborhood in Miami, ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a central focus on Alzheimer’s disease. The Company’s lead compound AD04™ is an injectable therapy in the process of entering into a confirmatory Phase 2b clinical trials in Europe to evaluate safety and efficacy of the product in early Alzheimer’s Disease. The Company believes that AD04™ may act as an immunomodulator, stimulating and regulating the immune system to reduce AD pathology, rather than limiting therapy to the aggregation of the proteins present once pathology is present. The Company is also exploring additional approaches to mitigating neurodegenerative disease, which it believes will eventually have an overall impact on longevity.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 195 Nw 40th St, Miami,florida 33127,united States
- Industry
- Biotechnology
- Keywords
- Mountain View.
- HQ
- Miami, Florida
Advantage Therapeutics Inc. Questions
Advantage Therapeutics Inc.'s website is http://www.advantagetherapeutics.com
Advantage Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/advantage-therapeutics-inc
Advantage Therapeutics Inc. has
12 employees.
View email and phone details for 12
employees at Advantage Therapeutics Inc..
Advantage Therapeutics Inc.'s industry is
Biotechnology
Advantage Therapeutics Inc.'s top competitors are
Lifespan Research Institute,
Downpayments,
Kocomo,
Onchain Studios,
Founderpool,
Tesouro,
Paludan,
Cosmic Wire Inc,
Klothea Bio, Inc,
Spearmint Energy.
Advantage Therapeutics Inc.'s categories are Biotechnology
Advantage Therapeutics Inc.'s founding year is 2021
